Docalysis streamlines document management by automating data extraction and analysis from contracts and legal documents, enhancing efficiency for legal teams and compliance officers.
Docalysis is an **AI-powered document analysis platform** that enables users to instantly extract insights and answers from documents by engaging in natural conversation with their files[1][6]. The tool accepts multiple file formats including PDFs, TXT, CSV, and DOCX files, preprocessing documents to identify relevant context before leveraging ChatGPT to answer user questions with human-level accuracy[6][8]. Core capabilities include intelligent document summarization, batch processing of hundreds or thousands of files simultaneously, secure file storage with deletion options, and an API for programmatic integration into existing workflows[1][6]. Docalysis serves professionals across multiple domains—including financial analysts, lawyers, accountants, and researchers—who need to process large volumes of information efficiently, with particular strength in analyzing financial documents like 10-K reports and complex contracts[1][6]. The platform delivers measurable productivity gains, saving users approximately 95% of the time typically spent manually reviewing documents, allowing professionals to obtain answers to document-related questions in seconds rather than hours[3][7]. What distinguishes Docalysis is its combination of conversational AI interaction, multi-format support, enterprise-grade batch processing capabilities, and specialized optimization for document-intensive industries, making it a comprehensive solution for organizations seeking to streamline document review and compliance workflows[1][2][6].
The ToS does not explicitly address whether user data or documents are used to train AI models. Section 5 grants Docalys
The ToS does not explicitly address whether user data or documents are used to train AI models. Section 5 grants Docalys
High risk across multiple dimensions. Only use with public, non-sensitive data.
The ToS does not explicitly address whether user data or documents are used to train AI models. Section 5 grants Docalysis a broad license to use submitted content for 'providing the Docalysis service' and 'advertising, or promoting Docalysis,' but does not clarify if this includes model training. The vague language creates moderate concern without explicit protections or opt-out mechanisms.
“[ToS] 'By submitting content through Docalysis, you grant Docalysis a permanent, worldwide, non-exclusive, royalty-free license to reproduce such content for the purpose of providing the Docalysis service, displaying or utilizing the content, or people aware of, advertising, or promoting Docalysis.'”
Section 5 grants Docalysis a permanent, worldwide, non-exclusive, royalty-free license to user content with broad purposes including 'advertising, or promoting Docalysis.' Section 11 further grants a 'fully sublicensable' license to unsolicited submissions. These terms are perpetual and irrevocable with explicit sublicensing rights, creating high risk for company IP.
“[ToS] 'By submitting content through Docalysis, you grant Docalysis a permanent, worldwide, non-exclusive, royalty-free license to reproduce such content for the purpose of providing the Docalysis service, displaying or utilizing the content, or people aware of, advertising, or promoting Docalysis.'”
Section 3 mentions third-party payment processors but provides no detail on data sharing scope or DPA requirements. The ToS does not address sharing of user documents or content with other third parties, analytics providers, or sub-processors. This omission creates moderate concern as the extent of third-party access is unclear.
“[ToS] 'We may employ the use of third party services for the purpose of facilitating payment and the completion of Purchases. By submitting your information, you grant us the right to provide the information to these third parties.'”
The ToS does not specify data retention periods, deletion timelines, or account termination cleanup procedures. Section 9 mentions that termination 'may include deletion or altering of content or user information' but provides no guarantees or timeframes. The vague language creates moderate concern about how long company data remains accessible.
“[ToS] 'Termination or suspension of any account does not constitute monitoring on the part of Docalysis. Docalysis explicitly does not monitor content but may respond to inquiries which require actions such as termination or suspension.'”
Section 5 explicitly states that by submitting content, users grant Docalysis a permanent, worldwide, non-exclusive, royalty-free license. While the ToS acknowledges users retain rights to their own content, the broad license granted to Docalysis for 'advertising, or promoting Docalysis' and the sublicensing rights in Section 11 mean the company cannot assert exclusive ownership over generated content.
“[ToS] 'By submitting content through Docalysis, you grant Docalysis a permanent, worldwide, non-exclusive, royalty-free license to reproduce such content for the purpose of providing the Docalysis service, displaying or utilizing the content, or people aware of, advertising, or promoting Docalysis.'”
The ToS makes no mention of SOC 2, ISO 27001, GDPR compliance, HIPAA, or any security certifications. Section 8 disclaims liability for unauthorized access to personally identifiable information with only a vague reference to 'good-faith effort to protect' data. No security documentation, trust page, or DPA is referenced in the provided documents.
“[ToS] 'Docalysis makes a good-faith effort to protect personally identifiable information about you, as explained in the associated Privacy Policy, but Docalysis disclaims any and all liability for any unauthorized access to or use of your personally identifiable information.'”
Track and measure your AI tools with Olakai's observability platform.
Explore Olakai